Equity Analysis

Quarterly Results

    Bliss GVS Pharma Ltd
    Industry :  Pharmaceuticals - Indian - Formulations
    BSE Code
    ISIN Demat
    Book Value()
    506197
    INE416D01022
    97.2265068
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    BLISSGVS
    16.19
    1313.44
    EPS(TTM)
    Face Value()
    Div & Yield %:
    7.7
    1
    0.4
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales179.59182.65148.96
Other Operating Income0.000.000.00
Other Income 11.668.356.84
Total Income191.25191.00155.80
Total Expenditure 153.86157.27122.22
PBIDT37.4033.7333.58
Interest 0.673.451.17
PBDT36.7330.2932.41
Depreciation6.966.396.26
Tax10.278.747.03
Fringe Benefit Tax0.000.000.00
Deferred Tax-1.55-1.90-0.29
Reported Profit After Tax21.0517.0419.42
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item21.0517.0419.42
EPS (Unit Curr.)2.001.631.85
EPS (Adj) (Unit Curr.)2.001.631.85
Calculated EPS (Unit Curr.)2.001.621.85
Calculated EPS (Adj) (Unit Curr.)2.001.621.85
Calculated EPS (Ann.) (Unit Curr.)7.996.487.41
Calculated EPS (Adj) (Ann.) (Unit Curr.)7.996.487.41
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity10.5410.5110.49
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)20.8318.4722.54
PBDTM(%)20.4516.5821.76
PATM(%)11.729.3313.04
Dividend Per Share(Rs)0.000.000.00
Diluted EPS2.001.631.81